INO Good advise, quito. I usually never venture a recommendation, seeing it as enough to let newbees know between the breathless exhortations that INO is a forty (40) year failure without a single (0) approved product, $800 million in losses and a Reverse Split history. That it was started by a notorious Vancouver penny stock promotor, Avtar Dhillon, uses discarded delivery technology and is employing a DNA based approach which has never worked in humans- that's why big pharma is not down this side street. But the share price is extended now on corona hype and will end badly, most often for new, unsuspecting investors when the sharpies pull the rug and INO comes plummeting down, like it does time and time again. That's what pump & dumps do. So I suggested Friday they get out and thank their lucky stars they didn't get scorched.
News 
Market Data 
Discover 
